arrow
H

Hildur Helgadóttir

karolinska institutet
H指数:26
被引数:2,644

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Time of day of neoadjuvant immune checkpoint inhibitor administration is associated with survival but not pathological response in resectable stage III–IV melanoma: a retrospective cohort study

一天中新辅助免疫检查点抑制剂给药时间与可切除III-IV期黑色素瘤患者的生存相关,但与病理反应无关:一项回顾性队列研究

2026-05-230
OAAI
Physical examinations and whole-body imaging versus physical examinations alone during follow-up after radical surgery of stage IIB–C and III cutaneous malignant melanoma (TRIM): an interim analysis of a multicentre, randomised, phase 3 trial in Sweden

物理检查和全身影像学检查与仅进行物理检查在IIB–C期和III期皮肤恶性黑色素瘤根治术后随访期间的应用比较(TRIM):一项在瑞典进行的多中心、随机、III期试验的期中分析

2025-10-270
PRE
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)
2024-11-011
OAAI
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

抗PD-1疗法在儿童和青少年黑色素瘤患者中的疗效(MELCAYA研究)

2024-09-010
PRE
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial
2024-01-020
OAAI
Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome
2023-10-015
OA
Brain metastases and survival evaluation in the SECOMBIT trial
2023-10-010
OAAI